Reach your target group. Post a job, event or news announcement on MalariaWorld
Is advertising on MalariaWorld effective? That's up to you to decide. Here are some examples:
- the event announcement of the 6th International Conference on Plasmodium vivax Research reached 3.996 people on MalariaWorld Facebook within a fews days
- a job announcement from the London School of Hygiene & Tropical Medicine had >3000 reads on MalariaWorld
- a fellowship announcement from the Malaria Research Capacity Development (MARCAD) Consortium in West and Central Africa had >3000 reads on MalariaWorld
- an interview with Prof Daouda Ndiaye had >2000 reads on MalariaWorld
- an In Memoriam about Anuj Shah (former CEO of A-Z Textile Mills Ltd) had > 2300 reads on MalariaWorld
Just to name a few... So do you want to reach the global professional malaria community with you announcement? Submit your announcement to email@example.com. MalariaWorld currently has >9100 members from 140 countries. We deliver your announcement right at the doorstep of our members. For conditions, prices and more information about advertising on MalariaWorld click here. We will do our utmost best to help you in any way we can.
Personal story: Nigerian PhD student Soniran's visit to Cornell University, USA
The Nigerian PhD student, Soniran Temidayo visited Cornell University in the USA to study malaria drug resistance. Members of MalariaWorld donated money to make this possible. Read Soniran's personal story here.
Event: BioMalPar XIII: Biology and Pathology of the Malaria Parasite
The 13th BioMalPar conference will take place 29-31 May 2017 at EMBL Heidelberg, Germany. This will be an opportunity to share ideas and develop new worldwide collaborations, as well serve as a training opportunity for the next generation of malaria researchers and scientists from malaria endemic countries. Read more about the 13th BioMalPar conference Biology and Pathology of the Malaria Parasite here.
Job: Postdoctoral Fellow malaria vaccine candidates
There is now an opening for a two-year post-doctoral fellowship position working in the Rayner lab at the The Sanger Institute Malaria Programme (UK) to prioritise vaccine targets operating during Plasmodium erythrocyte invasion. Closing date for applications: 9th February 2017. Read more about the vacancy for Postdoctoral Fellow malaria vaccine candidates here.
Event Update: 6th International Conference on Plasmodium vivax Research
The announcement/poster of this event has been updates with additional speakers. Find the updated information about the 6th International Conference on Plasmodium vivax Research here.
Enjoy this week's MalariaWorld - the MW team
Support MalariaWorld to provide Open Access to malaria information for all. We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at firstname.lastname@example.org
MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, you don’t pay to read, and authors get paid € 150 for each published paper. Read about MW and how you can submit your manuscript here.
Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to www.malariaworld.org, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.
Soniran Temidayo is a Nigerian PhD student. He travelled to Cornell University in the USA to study malaria drug resistance. Members of MalariaWorld donated money to make this life-changing experience possible for Soniran. A big thank you to you all to make this happen!
The "World Malaria Report 2016" draws on data from 91 countries and areas with ongoing malaria transmission. The information is supplemented by data from national household surveys and databases held by other organizations.
This year's report tracks progress towards the 2020 malaria goals of the "Global Technical Strategy for Malaria 2016-2030". It offers an in-depth analysis of trends in malaria control and elimination at global, regional and country levels.
The World Health Organization confirmed on 17 November that the world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa. Vaccinations will start in 2018.
The vaccine, known as RTS,S, acts against P. falciparum, the most deadly malaria parasite globally, and the most prevalent in Africa. Advanced clinical trials have shown RTS,S to provide partial protection against malaria in young children.
This infographic displays data from the World Health Organization’s “Projections of mortality and causes of death, 2015 and 2030”. The report details all deaths in 2015 by cause and makes predictions for 2030, giving an impression of how global health will develop over the next 14 years. Also featured is data from geoba.se showing how life expectancy will change between now and 2030.
SciDev.Net article - 21-09-2016
illumigene® Malaria, a novel, highly accurate test developed by Meridian Bioscience, has been awarded the coveted Journées Internationales de Biologie prize for Innovation in emergency treatment and point of care testing.
I am delighted to welcome Dr Fred Binka as Coordinator of WHO’s Emergency Response to Artemisinin Resistance (ERAR) hub in Phnom Penh, Cambodia.